Stay updated on Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page
- Check5 days agoChange DetectedThe page shows a new revision tag, v3.6.2, indicating an updated version. The previous revision tag, v3.6.0, has been removed along with Melanoma, the related topics header, and MedlinePlus Genetics from the page.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now indicates that recruitment has ended for this study, and adds user-help sections (How to Read a Study Record, Common Questions, How to Join a Study) to aid navigation. A formatting change updates the label from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag advances from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check27 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a new page/version release.SummaryDifference0.0%

- Check41 days agoChange DetectedMelanoma is now listed under related topics, and MedlinePlus Genetics is included in related topics. The revision tag shows Revision: v3.5.4, replacing the previous v3.5.3.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded the revision tag Revision: v3.5.3 and removed the older Revision: v3.5.2. Deleted the Melanoma entry and the related topics section, including MedlinePlus Genetics, from the page.SummaryDifference0.2%

- Check77 days agoChange DetectedRevision indicator updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Alone in Stage III Melanoma Clinical Trial page.